Skip to main content

Table 3 Dose reduction and/or delay in patients with HIV and concomitant CRC according to antiviral regimens (n = 66)

From: Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer

 

DTG/3TC/TDF (group I) n = 20

DTG/ABT (group II) n = 24

BIC/TAF/FTC (group III)

n = 22

Delayed chemotherapy

0

1

0

Dose reduction of chemotherapy

0

1

0

Interruption of chemotherapy

0

0

1

  1. CRC = colorectal cancer
  2. DTG/3TC/TDF = dolutegravir/lamivudine/tenofovir
  3. DTG/ABT = dolutegravir/albuvirtide
  4. BIC/TAF/FTC = bictegravir/tenofovir alafenamide/emtricitabine
Back to article page

AIDS Research and Therapy

ISSN: 1742-6405

Contact us